Gene: ZNF891
Official Full Name: zinc finger protein 891provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11902 | ZNF891 Knockout cell line (HeLa) | Human | ZNF891 | 1:3~1:6 | Negative | Online Inquiry |
KO11903 | ZNF891 Knockout cell line (HEK293) | Human | ZNF891 | 1:3~1:6 | Negative | Online Inquiry |
KO11904 | ZNF891 Knockout cell line (A549) | Human | ZNF891 | 1:3~1:4 | Negative | Online Inquiry |
ZNF891 Gene Knockout Cell Lines are specialized cell lines that have undergone precise genetic modifications to disable the ZNF891 gene. This gene encodes a zinc finger protein implicated in various cellular processes, including transcriptional regulation and cellular signaling pathways. By utilizing CRISPR-Cas9 technology or other gene-editing techniques, our knockout cell lines provide a robust tool for clarifying the biological role of ZNF891 and its involvement in disease mechanisms.
The primary function of these cell lines is to facilitate in-depth studies on gene function, cellular behavior, and responses in various biological contexts. The knockout of ZNF891 enables researchers to investigate the downstream effects on gene expression, protein interactions, and metabolic pathways, providing crucial insights into its physiological significance. In clinical research, understanding these functions can shed light on the pathogenesis of diseases such as cancer, neurodegenerative disorders, and other conditions associated with dysregulated gene expression.
The scientific importance of ZNF891 gene knockout cell lines lies in their capability to offer a reliable model for functional genomics studies and drug discovery. Unlike traditional methods that often rely on overexpression systems, these knockout models allow researchers to observe the genuine absence of gene function, leading to more accurate physiological interpretations. Moreover, they are vital in validating targets for therapeutic intervention and elucidating mechanisms of action for potential drug candidates.
Our ZNF891 Gene Knockout Cell Lines stand out from alternatives due to their high fidelity in gene disruption, verified off-target analysis, and comprehensive documentation of the knockout efficiency. This guarantees that researchers can rely on the specificity and integrity of their results, minimizing the uncertainties typically associated with less precise models.
In summary, the ZNF891 Gene Knockout Cell Lines offer significant value to researchers and clinicians by enabling groundbreaking insights into gene function and disease mechanisms. Our commitment to quality and excellence in producing these cell lines reflects our expertise in genetic engineering and dedication to advancing scientific discovery. Partnering with us provides access to cutting-edge tools that empower the next wave of research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.